| __timestamp | Dynavax Technologies Corporation | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 17763000 | 5078000000 |
| Thursday, January 1, 2015 | 22180000 | 4717000000 |
| Friday, January 1, 2016 | 37257000 | 5096000000 |
| Sunday, January 1, 2017 | 27367000 | 4986000000 |
| Monday, January 1, 2018 | 64770000 | 4214000000 |
| Tuesday, January 1, 2019 | 74986000 | 3806000000 |
| Wednesday, January 1, 2020 | 79256000 | 3671000000 |
| Friday, January 1, 2021 | 100156000 | 3528000000 |
| Saturday, January 1, 2022 | 131408000 | 3445000000 |
| Sunday, January 1, 2023 | 152946000 | 3498000000 |
| Monday, January 1, 2024 | 3702000000 |
Infusing magic into the data realm
In the competitive pharmaceutical industry, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Over the past decade, Teva Pharmaceutical Industries Limited and Dynavax Technologies Corporation have taken different paths in optimizing these costs. From 2014 to 2023, Teva's SG&A expenses decreased by approximately 31%, reflecting a strategic focus on cost efficiency. In contrast, Dynavax saw a significant increase of over 760% in the same period, indicating a potential investment in growth and expansion.
Teva's peak SG&A expenses in 2014 were nearly 5.1 billion, while Dynavax started at a modest 17.8 million. By 2023, Dynavax's expenses rose to 153 million, still a fraction of Teva's 3.5 billion. This divergence highlights the different strategies employed by these companies in navigating the pharmaceutical landscape.
Who Optimizes SG&A Costs Better? Sanofi or Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Limited or BeiGene, Ltd.: Who Manages SG&A Costs Better?
Teva Pharmaceutical Industries Limited and Viatris Inc.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Teva Pharmaceutical Industries Limited vs Sarepta Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Teva Pharmaceutical Industries Limited and Cytokinetics, Incorporated
Teva Pharmaceutical Industries Limited and Verona Pharma plc: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Teva Pharmaceutical Industries Limited and Vericel Corporation
Who Prioritizes Innovation? R&D Spending Compared for Teva Pharmaceutical Industries Limited and Dynavax Technologies Corporation
Comparing SG&A Expenses: Intra-Cellular Therapies, Inc. vs Dynavax Technologies Corporation Trends and Insights
Cost Management Insights: SG&A Expenses for Blueprint Medicines Corporation and Dynavax Technologies Corporation
Madrigal Pharmaceuticals, Inc. and Dynavax Technologies Corporation: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Vericel Corporation vs Dynavax Technologies Corporation